Connect with us
[ad_1] Newswise — HOUSTON & POHANG, South Korea – The University of Texas MD Anderson Cancer Center and C-Biomex Ltd. today announced a strategic research collaboration agreement...
[ad_1] Subcutaneous formula slashes treatment time to under 5 minutes Broad impact seen for greater access to and experience with treatment Study has implications for treatment...
[ad_1] Newswise — A new study led by Yale Cancer Center researchers at Yale School of Medicine revealed a significant increase in patients starting immunotherapy within...
[ad_1] Newswise — SAN DIEGO ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a...
[ad_1] Newswise — SAN DIEGO ― The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with...
[ad_1] Newswise — Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for...
[ad_1] Newswise — HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Data Science in Oncology (IDSO),...
[ad_1] Newswise — New York, October 27, 2023 The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the immune system’s power to control and...
[ad_1] Newswise — Boston – A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial...
[ad_1] Newswise — MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS)...
[ad_1] Newswise — Boston – Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,...
[ad_1] Newswise — SINGAPORE ― Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as...
[ad_1] Newswise — Treatment planning for lung cancer can often be complex due to variations in assessing immune biomarkers. In a new study, Yale Cancer Center...
[ad_1] Newswise — Although immunotherapies have shown promise in treating non-small cell lung cancer (NSCLC), many patients still do not respond well, and those who do...
[ad_1] Newswise — HOUSTON and SAN MATEO, Calif. ― The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana...
[ad_1] The image on the left shows raw data, and the image on the right shows how SparkMaster 2 detects calcium sparks, miniwaves and waves. (SACRAMENTO)...
[ad_1] Newswise — Boston – The Pancreatic Cancer Action Network (PanCAN), a leading non-profit in the fight against pancreatic cancer, has awarded Dana-Farber Cancer Institute researchers...
[ad_1] Newswise — (SACRAMENTO, Calif.) — Ophthalmologists at UC Davis Health used an experimental gene therapy last month to treat a patient with wet age-related macular degeneration,...
[ad_1] Newswise — New Brunswick, N.J., August 14, 2023 – Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with...
[ad_1] Newswise — PLYMOUTH MEETING, PA [August 9, 2023] — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced new grants awarded to...